Advanced Search

Submit Manuscript

Volume 15, No 9, Sep 2005

ISSN: 1001-0602 
EISSN: 1748-7838 2018 
impact factor 17.848* 
(Clarivate Analytics, 2019)

Volume 15 Issue 9, September 2005: 679-690

REVIEWS

Dynamic and reversibility of heterochromatic gene silencing in human disease

Giuseppe ZARDO1,2, Francesco FAZI2,3, Lorena TRAVAGLINI2,3, Clara NERVI2,3,*

1Departments of Cellular Biotechnology and Hematology, University of Rome "La Sapienza", Via di Castel Romano 100,
Rome 00128, Italy

2San Raffaele Bio-medical Science Park of Rome, Via di Castel Romano 100, Rome 00128, Italy


3Departments of Histology and Medical Embryology, University of Rome "La Sapienza", Via di Castel Romano 100, Rome
00128, Italy
Correspondence: Clara NERVI(clara.nervi@uniroma1.it)

In eukaryotic organisms cellular fate and tissue specific gene expression are regulated by the activity of proteins known as transcription factors that by interacting with specific DNA sequences direct the activation or repression of target genes. The post genomic era has shown that transcription factors are not the unique key regulators of gene expression. Epigenetic mechanisms such as DNA methylation, post-translational modifications of histone proteins, remodeling of nucleosomes and expression of small regulatory RNAs also contribute to regulation of gene expression, determination of cell and tissue specificity and assurance of inheritance of gene expression levels. The relevant contribution of epigenetic mechanisms to a proper cellular function is highlighted by the effects of their deregulation that cooperate with genetic alterations to the development of various diseases and to the establishment and progression of tumors.


FULL TEXT | PDF

Browse 1899